Navigation Links
Piraeus Licenses Misys BankFusion Equation to Deliver Products
Date:2/1/2010

LONDON, February 1 /PRNewswire-FirstCall/ --

- Faster Than its Competition and to Strengthen Expansion Plans

Misys plc (LSE: MSY), the global application software and services company, today announces that Piraeus Bank, the Athens-based universal bank, has licensed Misys BankFusion Equation as the technology platform to underpin its expansion plans.

Misys Equation has added value to Piraeus Bank's operations for many years across its domestic and selected international branches, using Equation to run the bank's operations across 343 branches in Greece and 220 branches in three of its international subsidiaries. Piraeus went live with Equation 3.9 in its Albanian operations in 2008 and Romanian business in 2009. The implementations were an important part of the bank's growth strategy and has helped Piraeus to continue to achieve its business ambitions, as it continues to expand in South-Eastern Europe and the Eastern Mediterranean markets. Its future growth objectives in its domestic and international operations will be accelerated by BankFusion Equation.

In this latest release of the solution, Equation has been re-architected into an SOA environment using Misys' revolutionary BankFusion(TM) platform. Misys BankFusion Equation delivers Java (J2EE) re-usable components to Piraeus and gives it improved security and risk management capabilities and the flexibility to scale the business rapidly. BankFusion Equation automatically generates the system's Java code, significantly reducing manual input and errors and accelerating solution modifications.

"It is imperative that we move faster than our competition," states Janis Delis, DGM - Operations Technology and Organisation, Piraeus Bank. "Our investment in Misys and its BankFusion Equation solution is critical in our desire to maintain our competitive edge as we continue to expand and to be agile and innovative for our customers. The revolutionary technology in BankFusion Equation will allow us to launch innovative new products and services quickly that would normally take months of development with other core banking systems and seamlessly integrate best of breed solutions. We look forward to continuing to receive the support we have received over the fruitful relationship we have had with Misys, and to strengthening our position in retail banking and enterprise financing still further."

Guy Warren, EVP and General Manager, Banking, Misys states, "The management team at Piraeus has chosen to invest in Misys, our BankFusion strategy and the future roadmap of the solution. This will give them a unique ability to tailor their business processes to the exact requirements of the organisation, without having to replace the existing underlying technology, and enable them to stay ahead of the competition."

About Misys plc

Misys plc (FTSE: MSY.L), provides integrated, comprehensive solutions that deliver significant results to organisations in the financial services and healthcare industries. We maximise value for our customers by combining our deep knowledge of their business with our commitment to their success.

In banking and treasury & capital markets, Misys is a market leader, with over 1,200 customers, including all of the world's top 50 banks. In healthcare, Misys plc owns a controlling stake in NASDAQ-listed Allscripts-Misys Healthcare Solutions, Inc, a clear leader in the provision of healthcare technology, serving more than 150,000 physicians, 700 hospitals and nearly 7,000 post-acute and homecare organisations. Misys employs around 6,000 people who serve customers in more than 120 countries.

We aspire to be the world's best application software and services company, delivering results for the most important industries in the world.

    Misys: experience, solutions, results
    Contact us today, visit: http://www.misys.com

    For further information please contact

    Edward Taylor
    Global Head of Public Relations
    Misys
    Solutions for Banking and Treasury & Capital Markets
    +44(0)20-3320-5530
    edward.taylor@misys.com

    Sebastian Mathews
    Financial Dynamics
    +44(0)207-269-7158
    sebastian.mathews@fd.com

SOURCE Misys plc


'/>"/>
SOURCE Misys plc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Osseon Therapeutics, Inc. Announces it has Received Canadian Medical Device Licenses From Health Canada
2. Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend
3. Quantros Licenses Adverse Event Identification Technology from University of Michigan
4. U.S. FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine
5. Catalyst Pharmaceutical Partners Licenses Exclusive Rights to New Class of GABA Aminotransferase Inhibitors From Northwestern University
6. Professional Healthcare Is Approved for Medicare Licenses at Additional Offices in California and Utah
7. Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.
8. Global Med Technologies(R) Licenses Transfusion Software Solution to Nationwide Healthcare System
9. Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines(R)
10. Echo Therapeutics Licenses Needle-Free Prelude SkinPrep System to Ferndale Pharma for Enhanced Delivery of Topical Lidocaine
11. Global Med Technologies(R), Inc. Licenses and Deploys its EdgeLab Laboratory Software at Eugene Andre Hospital in Lyon, France
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... , ... February 13, 2016 , ... ... of Nursing with an in-kind gift of a VeinViewer® Vision vein finder ... they learn how to start an IV and draw blood, combining technology with ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mystic Buddha Publishing House presents Valentine’s ... Buddha, the biography of Rama - Dr. Frederick Lenz. , According to ... of a Buddhist teacher for teaching and helping others. Valentine’s Day celebrates love ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose ... – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose ... products, garnering increased attention from all stakeholders in the development of new chemical ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... Zuckerberg San Francisco General Hospital on April 5-7. The series is a multi-day, ... new habits. The workshops cover a broad range of topics, including coaching skills, ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Jones Agency, a family owned ... Texas, is launching a cooperative charity drive with the Tarrant Area Food Bank in ... 50,000 individuals and families in need, the Tarrant County Food Bank offers hope and ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... INDIANAPOLIS , Feb. 12, 2016  Eli Lilly and ... High Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent ... in the UK, France , ... instructions to dilute the product only with dextrose solution.  ... of 2015, the UK Court of Appeal held that Lilly,s ...
(Date:2/12/2016)... Ky. , Feb. 12, 2016 /PRNewswire/ ... has completed a $47.1 million Series D ... Cormorant Asset Management, Hillhouse Capital Group and ... Morningside Venture Investments, AJU IB Investment, and ... be used to further advance clinical trials ...
(Date:2/11/2016)... The primary goal of this research is to analyze ... of liquid biopsy. Key information the survey seeks to ... liquid biopsy adoption amidst future users - Predominantly used ... Sample inflow to conduct liquid biopsy tests - Preference ... on. - Correlation analysis of sample type and biomarker ...
Breaking Medicine Technology: